You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATI 7505

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroparesis Trial (Naronapride, Placebo)

Recruiting
  • Gastroparesis
  • Leuven, Belgium
    University of Leuven
Feb 1, 2023

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023

Post Analytic Treatment Interruption Study

Recruiting
  • HIV
    • Bangkok, Thailand
      SEARCH
    Oct 19, 2022

    Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound

    Not yet recruiting
    • Hepatic Steatosis
    • +2 more
      • Seoul, Korea, Republic of
        Asan Medical Center
      May 21, 2023

      Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

      Recruiting
      • Rheumatoid Arthritis
      • ATI-450 50mg oral tablet BID
      • +3 more
      • El Cajon, California
      • +24 more
      Jan 27, 2023

      Atopic Dermatitis Trial in United States (ATI-1777 2.0% w/w, ATI-1777 1.0% w/w, ATI-1777 0.5% w/w)

      Recruiting
      • Atopic Dermatitis
      • ATI-1777 2.0% w/w
      • +3 more
      • Birmingham, Alabama
      • +25 more
      Jun 20, 2022

      HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

      Recruiting
      • HIV Infection
      • Analytical Treatment Interruption
      • Los Angeles, California
      • +11 more
      Jan 13, 2023

      Metabolic Associated Fatty Liver Disease in Chinese Population

      Completed
      • Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 13, 2022

        Psoriatic Arthritis Trial in United States (ATI-450, Placebo Oral Tablet)

        Recruiting
        • Psoriatic Arthritis
        • Miami Lakes, Florida
        • +7 more
        Aug 19, 2022

        NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2, Hyperlipidemias Trial in Frankfurt, Mainz (Nutritional Intervention)

        Active, not recruiting
        • NASH - Nonalcoholic Steatohepatitis
        • +2 more
        • Nutritional Intervention
        • Frankfurt, Germany
        • +1 more
        Mar 28, 2022

        HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

        Not yet recruiting
        • HIV-1-infection
        • ChAdOx1.tHIVconsv1
        • +7 more
        • San Diego, California
        • +11 more
        Oct 4, 2023

        HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

        Recruiting
        • HIV Infection
        • N-803 (IL-15 Superagonist)
        • +2 more
        • Los Angeles, California
        • +11 more
        Sep 22, 2022

        HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

        Recruiting
        • HIV-1-infection
        • Umlazi, South Africa
          FRESH Clinical Research Site: Females Rising through Education,
        Jan 4, 2023

        Attenuation Imaging in Hepatic Steatosis

        Not yet recruiting
        • Hepatic Steatosis
        • +2 more
        • Attenuation imaging in ultrasonography
        • (no location specified)
        Mar 29, 2022

        Remimazolam, Awake Endotracheal Intubation Trial in Wuhan (Dos of Afentanil 20, Dos of Afentanil 30, Dos of Afentanil 40)

        Recruiting
        • Remimazolam
        • Awake Endotracheal Intubation
        • Dos of Afentanil 20
        • +8 more
        • Wuhan, Hubei, China
          Tongji Hospital, Tongji Medical College, Huazhong Science and Te
        Aug 30, 2023

        HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

        Recruiting
        • HIV Infection
        • Analytical Treatment Interruption
        • Gaborone, Botswana
        • +10 more
        May 16, 2022

        HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

        Not yet recruiting
        • HIV-1-infection
        • Molepolole, Botswana
        • +8 more
        Sep 8, 2023

        HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

        Not yet recruiting
        • HIV-1-infection
        • VRC07-523LS
        • +7 more
        • Pathum Wan, Bangkok, Thailand
        • +1 more
        Mar 8, 2023

        HIV-1-infection Trial in Worldwide (Saline, Lefitolimod, 3BNC117 and 10-1074)

        Active, not recruiting
        • HIV-1-infection
        • Salt Lake City, Utah
        • +7 more
        Mar 30, 2022

        Hidradenitis Suppurativa Trial in United States (ATI-450, Placebo oral tablet)

        Recruiting
        • Hidradenitis Suppurativa
        • Birmingham, Alabama
        • +18 more
        Feb 18, 2022

        Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

        Terminated
        • Hepatitis B, Chronic
        • Hepatitis D
        • Chisinau, Republic Of Moldova, Moldova, Republic of
        • +1 more
        Nov 15, 2022

        Atopic Dermatitis Trial in United States (ATI-1777, Vehicle)

        Completed
        • Atopic Dermatitis
        • Scottsdale, Arizona
        • +13 more
        Mar 10, 2022

        HIV/AIDS Trial in San Francisco (Combination Intervention)

        Active, not recruiting
        • HIV/AIDS
        • Combination Intervention
        • San Francisco, California
          Zuckerberg San Francisco General Hospital, University of Califor
        Mar 21, 2022

        HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

        Suspended
        • HIV Infections
        • Birmingham, Alabama
        • +5 more
        Jan 31, 2023

        Chronic Hepatitis b Trial in Chisinau, Kyiv (ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet)

        Terminated
        • Chronic Hepatitis b
        • ATI-2173 25mg
        • +2 more
        • Chisinau, Republic Of Moldova, Moldova, Republic of
        • +1 more
        May 25, 2022